Comments
Loading...
FluoroPharma Medical Analyst Ratings and Price Targets | OTC:FPMI | Benzinga
FluoroPharma Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for FluoroPharma Medical Corp from these most-recent analyst ratings.
Analyst Ratings for FluoroPharma Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for FluoroPharma Medical (FPMI) stock?
There is no price target for FluoroPharma Medical
What is the most recent analyst rating for FluoroPharma Medical (FPMI)?
There is no analyst for FluoroPharma Medical
When was the last upgrade for FluoroPharma Medical (FPMI)?
There is no last upgrade for FluoroPharma Medical
When was the last downgrade for FluoroPharma Medical (FPMI)?
There is no last downgrade for FluoroPharma Medical.
When is the next analyst rating going to be posted or updated for FluoroPharma Medical (FPMI)?
There is no next analyst rating for FluoroPharma Medical.
Is the Analyst Rating FluoroPharma Medical (FPMI) correct?
There is no next analyst rating for FluoroPharma Medical.
Browse analyst ratings and price targets on all stocks.
